News & Insights
Professionals
Focus Areas
Regions
Type
Sort By
Client News 3 Results
Client News
|November 3, 2025
Leerink Partners and Goldman Sachs & Co. LLC served as representatives of the underwriters in the common stock offering of Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on creating best-in-class therapies.
Client News
|March 12, 2025
Gunderson Dettmer Advises Tarsus Pharmaceuticals on Upsized Underwritten Public Offering
Biopharmaceutical company, Tarsus Pharmaceuticals, announces its March 2025 upsized underwritten public offering
Client News
|October 8, 2024
City Therapeutics Announces Launch with $135M Series A Financing
City Therapeutics announces its launch and $135 million Series A financing led by ARCH Ventures